deadline.com
Eric Wold
New York
film
2020
vaccine
Eric Wold
New York
Cinemark Gets Big Vote Of Confidence From Veteran Analyst, Who Sees “Return To Normalcy” For Movie Theaters
Reading now: 472
deadline.com
deadline.comVeteran exhibition analyst Eric Wold of B. Riley has given Cinemark stock a big shot in the arm, so to speak, upgrading it to “buy” from “neutral” and doubling his price target.In a note to clients, Wold said he held a “fireside chat” with the management of the major theater circuit earlier this week.
Despite the raging infection rates of Covid-19 across the country, which continue to keep a lid on major markets like LA and New York, Wold believes Cinemark is well-positioned during and after the pandemic.
He boosted his 12-month price target to $28 from $14. The company’s shares spiked in the opening minutes of trading this morning but have since settled into break-even territory at around $19.
Read more on deadline.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
Report this news
Related News
hollywoodreporter.com
Cinemark Analyst Upgrades Stock on "Next Leg of Recovery"
B.
Celebrities
Locations